✦ LIBER ✦

Incidence and predictors of hematological side effects in chronic HCV Egyptian patients treated with PEGylated interferon and ribavirin

✍ Scribed by A. H. Lashin, Y. A. Shaheen, M. A. Metwally…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

F-04 Incidence, predictors and managemen

✍ Angeli, E.; Cariti, G.; Carosi, G.; Pontali, E.; Cattelan, A.M.; Gulminetti, R.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Predictors of hematological abnormalitie

✍ Jagdish S. Nachnani; Gowtham A. Rao; Deepti Bulchandani; Prashant K. Pandya; Lau 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 90 KB

Incidence and risk factors of retinopath

✍ Yasser M. Fouad; Hanaa Khalaf; Hala Ibraheem; Heba Rady; Amal K. Helmy 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 328 KB

Effectiveness of Pegylated Interferon an

✍ J.M. Moreno Planas; E. Rubio González; E. Boullosa Graña; M. Fernández Ruiz; M. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 49 KB

F-02 Incidence and consequences of throm

✍ Cattelan, A.M.; Angeli, E.; Pontali, E.; Gulminetti, R.; Maida, I.; Nasta, P.; V 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Dyspnoea in patients with chronic hepati

✍ Garib, Junia Rios; Garcia, Guilherme Freire; Teixeira, Rosângela; Lima e Silva, 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 151 KB